Focus on RNA Therapy Breakthrough and Draw a Blueprint for the Next Generation of Vaccine Localization

Release time:

2023-08-04 17:18

In recent years, as a new biomedical technology, RNA therapy has received extensive attention. The breakthrough of RNA therapy lies in the use of the body's own RNA molecules to treat various diseases. In order to accelerate the development and application of RNA therapy, my country is drawing a blueprint for the localization of next-generation vaccines.

First of all, we will increase investment in research and development in the field of RNA therapy to enhance the level of scientific research and technical capabilities. Through the introduction and training of scientific research personnel, strengthen international cooperation and exchanges, absorb and digest foreign advanced technology, and promote the breakthrough of RNA therapy. At the same time, we will also strengthen basic research and clinical trials, explore the potential of RNA therapy, and explore its application in the treatment of cancer, genetic diseases and other fields.

Second, we will establish a sound regulatory and regulatory system to ensure the safety and reliability of RNA therapy. Through the formulation of strict technical specifications and quality control standards, the research and development, production and clinical application of RNA therapy are comprehensively supervised to ensure the stability and reliability of efficacy, and improve the competitiveness and market share of domestic RNA therapy.

We will increase support for the industrialization of RNA therapy, and cultivate and guide the development of related enterprises. By providing policy support, financial support and technical services, enterprises are encouraged to increase R & D investment and promote the industrialization of RNA therapy. At the same time, we will also strengthen the protection of intellectual property rights, prevent technology loss and infringement, and improve the core competitiveness of domestic RNA therapy.

To sum up, China is focusing on the breakthrough of RNA therapy and is committed to drawing a blueprint for the localization of the next generation of vaccines. By increasing investment in research and development, establishing a regulatory system and supporting the development of industrialization, we are confident that we will make important breakthroughs in the field of RNA therapy and make greater contributions to the cause of human health.

Previous Page

Highlights of the 2023 edition of the draft guide: new testing items.

How much do you know about the raw materials of small nucleic acid drugs? A large supply of various types of nucleosides and their monomers

Next Page

RELATED INFORMATION

Related Downloads